Kerri E. Rieger

2.8k citations
103 papers · 2.1k · 1 hit paper · h-index 26

Impact in

  • Dermatology top 0.5%
    • Cutaneous lymphoproliferative disorders research
    • Chemotherapy-related skin toxicity
    • Skin and Cellular Biology Research

Papers in

    • Cutaneous lymphoproliferative disorders research 22
    • Cancer and Skin Lesions 4
    • Nonmelanoma Skin Cancer Studies 13
    • Inflammatory Myopathies and Dermatomyositis 5

Kerri E. Rieger

91 papers receiving 2k citations

Kerri E. Rieger's Hit Papers

Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial 2025 · 36 citations
360Years since publication102030

Peers

Kerri E. Rieger
Comparison fields: 5 of 72
  • Dermatology 538
  • Cell Biology 226
  • Oncology 327
  • Epidemiology 406
  • Pathology and Forensic Medicine 91
Replace Michael Tronnier with:
Michael Tronnier Germany
Nathalie Cardot‐Leccia France
Gundula Schaumburg‐Lever Germany
Guy Edward Orchard United Kingdom
Marie‐Hélène Aubriot‐Lorton France
Wolfgang Ch. Marsch Germany
Christopher P. Elco United States
Sandrine Poglio France
Patrick A. Oberholzer Switzerland
Alexandra C. Hristov United States
Kerri E. Rieger relative to Michael Tronnier Germany Michael Tronnier's profile →
Citations per field
00.5×2×4×6×7.1×
Michael Tronnier · 1×
Citations per year

Countries citing papers authored by Kerri E. Rieger

Since Specialization
Citations

This map shows the geographic impact of Kerri E. Rieger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerri E. Rieger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerri E. Rieger more than expected).

Fields of papers citing papers by Kerri E. Rieger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerri E. Rieger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerri E. Rieger. The network helps show where Kerri E. Rieger may publish in the future.

Co-authors

The 25 scholars most cited alongside Kerri E. Rieger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kerri E. Rieger Line = papers co-authored together Kerri E. Rieger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2016172
2 2018166
3 2004129
4 200498
5 201890
6 202090
7 201987
8 201773
9 202161
10 202058
11 202053
12 201548
13 201942
14 202042
15 200941
16 201638
17
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
Hit paper breakdown →
202536
18 201534
19 201734
20 202134

About Kerri E. Rieger

Kerri E. Rieger is a scholar working on Dermatology, Epidemiology, Oncology, Cell Biology and Pathology and Forensic Medicine, having authored 103 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cutaneous lymphoproliferative disorders research (22 papers), Nonmelanoma Skin Cancer Studies (13 papers), Skin and Cellular Biology Research (8 papers), Cutaneous Melanoma Detection and Management (8 papers), Inflammatory Myopathies and Dermatomyositis (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer and Skin Lesions (4 papers) and Hedgehog Signaling Pathway Studies (4 papers). The work is most often cited by research in Dermatology (538 citations), Cell Biology (226 citations), Oncology (327 citations), Epidemiology (406 citations) and Pathology and Forensic Medicine (91 citations). Kerri E. Rieger has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Kavita Yang Sarin, Bernice Y. Kwong, Ryanne A. Brown, Jean Yuh Tang, Jennifer Y. Wang, Roberto A. Novoa, Shyam S. Raghavan, Youn H. Kim, M. Peter Marinkovich and Alexander Dimitrios Colevas. Their work appears in journals such as Journal of Cutaneous Pathology, Journal of Investigative Dermatology, JAMA Dermatology, Journal of the American Academy of Dermatology and American Journal of Dermatopathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact